Gerresheimer AG/€GXI
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Gerresheimer AG
Gerresheimer AG is a prominent player in the healthcare and life sciences industry, specializing in the production of glass and plastic products for pharmaceutical and cosmetic packaging. The company’s key offerings include pharmaceutical vials, prefillable syringes, glass and plastic packaging for drugs, as well as delivery systems for the safe administration of medications. Founded in 1864, Gerresheimer has evolved into a global entity with headquarters in Düsseldorf, Germany, and operates manufacturing sites in Europe, the Americas, and Asia. Its strategic strength lies in a broad product portfolio and advanced technical expertise, enabling it to cater to the stringent requirements of its diverse clientele in the healthcare sector. The company’s comprehensive geographic footprint and commitment to innovation bolster its competitive position in the market.
Ticker
€GXI
Sector
Primary listing
XETRA
Employees
13,535
Headquarters
Website
Gerresheimer AG Metrics
BasicAdvanced
€1B
42.60
€0.68
0.76
€0.04
0.14%
Price and volume
Market cap
€1B
Beta
0.76
52-week high
€85.18
52-week low
€26.08
Average daily volume
144K
Dividend rate
€0.04
Financial strength
Current ratio
0.983
Quick ratio
0.406
Long term debt to equity
119.461
Total debt to equity
161.827
Dividend payout ratio (TTM)
0.43%
Interest coverage (TTM)
1.44%
Profitability
EBITDA (TTM)
384.986
Gross margin (TTM)
26.89%
Net profit margin (TTM)
1.04%
Operating margin (TTM)
6.86%
Effective tax rate (TTM)
27.40%
Revenue per employee (TTM)
€170,000
Management effectiveness
Return on assets (TTM)
2.34%
Return on equity (TTM)
1.81%
Valuation
Price to earnings (TTM)
42.602
Price to revenue (TTM)
0.442
Price to book
0.72
Price to tangible book (TTM)
-3.24
Price to free cash flow (TTM)
-2.266
Free cash flow yield (TTM)
-44.13%
Free cash flow per share (TTM)
-12.709
Dividend yield (TTM)
0.14%
Forward dividend yield
0.14%
Growth
Revenue change (TTM)
11.83%
Earnings per share change (TTM)
-79.57%
3-year revenue growth (CAGR)
9.28%
10-year revenue growth (CAGR)
5.36%
3-year earnings per share growth (CAGR)
-38.33%
10-year earnings per share growth (CAGR)
-11.17%
3-year dividend per share growth (CAGR)
-68.25%
10-year dividend per share growth (CAGR)
-25.41%
Bulls say / Bears say
Despite lowering its revenue outlook, Gerresheimer kept its adjusted EBITDA margin target at roughly 20%, highlighting stable profitability. (Reuters)
The company reiterated its mid-term revenue growth target of 6–9%, showing confidence in its long-term growth prospects despite current setbacks. (Reuters)
Warburg Pincus’s ongoing interest in acquiring Gerresheimer around €90 per share underlines the likelihood of a takeover premium and the attractiveness of the company to private equity. (Reuters)
Financial regulator BaFin has started an audit of Gerresheimer’s 2024 accounts over possible “bill-and-hold” revenue recognition issues, sending the stock to its lowest level in 13 years. (Reuters)
The company has twice lowered its 2025 revenue growth forecast and now expects just 0–2% growth, as sluggish demand for cosmetics and oral liquids weighs on results. (Reuters)
Gerresheimer shares have fallen about 29% so far this year, reflecting ongoing investor unease about the group’s strategy and profitability. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Gerresheimer AG stock?
Gerresheimer AG (GXI) has a market cap of €1B as of October 25, 2025.
What is the P/E ratio for Gerresheimer AG stock?
The price to earnings (P/E) ratio for Gerresheimer AG (GXI) stock is 42.6 as of October 25, 2025.
Does Gerresheimer AG stock pay dividends?
Yes, the Gerresheimer AG (GXI) stock pays dividends to shareholders. As of October 25, 2025, the dividend rate is €0.04 and the yield is 0.14%. Gerresheimer AG has a payout ratio of 0.43% on a trailing twelve-month basis.
When is the next Gerresheimer AG dividend payment date?
The next Gerresheimer AG (GXI) dividend payment date is unconfirmed.
What is the beta indicator for Gerresheimer AG?
Gerresheimer AG (GXI) has a beta rating of 0.76. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.